KZRKezar Life Sciences, Inc.

Nasdaq kezarlifesciences.com


$ 0.86 $ 0.00 (0.32 %)    

Friday, 03-May-2024 15:59:55 EDT
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 0.8574
$ 0.84
$ 0.00 x 0
$ 0.00 x 0
$ 0.84 - $ 0.86
$ 0.67 - $ 3.13
193,867
na
62.21M
$ 1.28
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-14-2024 12-31-2023 10-K
2 11-13-2023 09-30-2023 10-Q
3 08-10-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-14-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-11-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-17-2022 12-31-2021 10-K
10 11-09-2021 09-30-2021 10-Q
11 08-12-2021 06-30-2021 10-Q
12 05-12-2021 03-31-2021 10-Q
13 03-11-2021 12-31-2020 10-K
14 11-05-2020 09-30-2020 10-Q
15 08-06-2020 06-30-2020 10-Q
16 05-07-2020 03-31-2020 10-Q
17 03-12-2020 12-31-2019 10-K
18 11-07-2019 09-30-2019 10-Q
19 08-07-2019 06-30-2019 10-Q
20 05-07-2019 03-31-2019 10-Q
21 03-26-2019 12-31-2018 10-K
22 11-08-2018 09-30-2018 10-Q
23 08-09-2018 06-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-kezar-life-sciences-maintains-20-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Kezar Life Sciences (NASDAQ:KZR) with a Buy and maintains $20 ...

 kezar-life-sciences-q4-eps-044-misses-038-estimate

Kezar Life Sciences (NASDAQ:KZR) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of ...

 reported-late-monday-everest-medicines-and-kezar-life-sciences-received-ind-approval-from-chinas-nmpa-for-the-palizade-trial-in-lupus-nephritis

Everest Medicines (HKEX 1952.HK) and Kezar Life Sciences, Inc. (NASDAQ:KZR) announced today that the Center for Drug Evaluation...

 as-oversupply-deflates-lithium-bubble-ipo-market-keeps-in-high-spirits

Lithium market facing persistent turmoil as spot prices decline for more than a year. But asset management firm Janus Henderson...

 hc-wainwright--co-reiterates-buy-on-kezar-life-sciences-maintains-20-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Kezar Life Sciences (NASDAQ:KZR) with a Buy and maintains $20 ...

 hc-wainwright--co-reiterates-buy-on-kezar-life-sciences-maintains-20-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Kezar Life Sciences (NASDAQ:KZR) with a Buy and maintains $20 ...

 wells-fargo-maintains-equal-weight-on-kezar-life-sciences-lowers-price-target-to-2

Wells Fargo analyst Derek Archila maintains Kezar Life Sciences (NASDAQ:KZR) with a Equal-Weight and lowers the price target...

 kezar-life-sciences-q3-eps-032-beats-035-estimate-sales-700k

Kezar Life Sciences (NASDAQ:KZR) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(...

 hc-wainwright--co-reiterates-buy-on-kezar-life-sciences-maintains-20-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Kezar Life Sciences (NASDAQ:KZR) with a Buy and maintains $20 ...

 stocks-that-hit-52-week-lows-on-thursday

  On Thursday, 369 companies hit new 52-week lows.

 jonestrading-downgrades-kezar-life-sciences-to-hold

JonesTrading analyst Catherine Novack downgrades Kezar Life Sciences (NASDAQ:KZR) from Buy to Hold.

 stocks-that-hit-52-week-lows-on-wednesday

  On Wednesday, 311 stocks hit new 52-week lows.

 hc-wainwright--co-maintains-buy-on-kezar-life-sciences-raises-price-target-to-20

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Kezar Life Sciences (NASDAQ:KZR) with a Buy and raises the pric...

 stocks-that-hit-52-week-lows-on-thursday

  During the session on Thursday, 461 stocks hit new 52-week lows.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION